Cathay Biotech Inc (688065) — Cash Flow Reinvestment Rate
Cathay Biotech Inc (688065) has a Cash Flow Reinvestment Rate of 0.31x as of June 2025, reinvesting CN¥78.51 Million (capex CN¥78.51 Million ) from operating cash flow of CN¥251.82 Million. Check 688065 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cathay Biotech Inc Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Cathay Biotech Inc across 7 annual periods. Explore 688065 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Cathay Biotech Inc (2017–2024)
Year-by-year capital reinvestment analysis for Cathay Biotech Inc. For live market cap and broader valuation context, see how much is Cathay Biotech Inc worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.03x | CN¥1.67 Billion | CN¥820.93 Million | CN¥843.31 Million | ▼ -63.1% |
| 2023 | 5.49x | CN¥3.13 Billion | CN¥569.45 Million | CN¥1.57 Billion | ▼ -47.4% |
| 2022 | 10.45x | CN¥8.40 Billion | CN¥803.67 Million | CN¥4.20 Billion | ▲ +287.8% |
| 2021 | 2.69x | CN¥1.60 Billion | CN¥594.18 Million | CN¥1.47 Billion | ▼ -29.2% |
| 2020 | 3.81x | CN¥1.96 Billion | CN¥514.96 Million | CN¥763.11 Million | ▼ -20.3% |
| 2019 | 4.78x | CN¥1.72 Billion | CN¥359.62 Million | CN¥511.14 Million | ▼ -74.3% |
| 2017 | 18.62x | CN¥995.09 Million | CN¥53.45 Million | CN¥995.09 Million | — |